231 results match your criteria: "Treatment Research Institute[Affiliation]"

Substance use is pervasive among youth, particularly among those involved in the juvenile justice system. Juvenile drug courts (JDCs) are a promising approach for delinquent youth with substance abuse issues. However, research regarding JDCs has shown inconsistent effects, and little is known about the specific components associated with positive outcomes.

View Article and Find Full Text PDF

Medicaid coverage of medications to treat alcohol and opioid dependence.

J Subst Abuse Treat

August 2015

Truven Health Analytics, 7700 Old Georgetown Road, Bethesda, MA, 20814. Electronic address:

Substance use disorders affect 12% of Medicaid beneficiaries. The prescription drug epidemic and growing need for treatment of alcohol and opioid dependence have refocused states' attention on their provision of substance use disorder treatment services, including medications. This study characterized how Medicaid programs cover these treatment medications.

View Article and Find Full Text PDF

Parents experience a variety of challenges when they are confronted with the fact that their adolescent child is drinking alcohol or using other substances. This special issue is focused on the work being conducted at the NIDA-funded Parents Translational Research Center (PTRC) at the Treatment Research Institute in Philadelphia. By translating scientific evidence and elements of proven clinical interventions into practical tools for parents, the work of the PTRC aims to assist parents with assistance in intervening early, finding appropriate services and facilitating treatment entry for their substance-using child.

View Article and Find Full Text PDF

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?

J Addict Med

April 2016

From the New York State Psychiatric Institute and Department of Psychiatry (EVN), Columbia University, New York, NY; Bekhterev Research Psychoneurological Institute and St Petersburg State Pavlov Medical University (EK), Russia; Department of Psychiatry and Biobehavioral Sciences (WL), University of California, Los Angeles, CA; Alkermes, Inc (JZ, AM, BLS), Waltham, MA; and Treatment Research Institute (DRG), Philadelphia, PA.

Objectives: Once-monthly intramuscular extended-release naltrexone (XR-NTX) has demonstrated efficacy for the prevention of relapse in opioid dependence, providing an alternative to agonist or partial agonist maintenance (ie, methadone and buprenorphine). The question remains, for whom is this unique treatment most efficacious and can patient-treatment matching factors be identified?

Methods: A moderator analysis was conducted on a previously reported 24-week, placebo-controlled, multisite, randomized controlled trial of XR-NTX (n = 126) versus placebo (n = 124) among recently detoxified opioid-dependent adults in Russia, which showed XR-NTX superior to placebo in proportion of opioid abstinent weeks. The moderator analysis examined a dichotomous indicator of good clinical response-achieving at least 90% of weeks abstinent over the 24-week trial.

View Article and Find Full Text PDF

We describe a project focused on training parents to facilitate their treatment-resistant adolescent's treatment entry and to manage their child after entry into community-based treatment. Controlled studies show that Community Reinforcement and Family Training (CRAFT) is a unilateral treatment that fosters treatment entry of adults; however, there are no controlled trials for parents with a substance-abusing child. We examined the behavioral parent training literature to guide us in tailoring CRAFT for parents of adolescents.

View Article and Find Full Text PDF

This study examined US state laws regarding parental and adolescent decision-making for substance use and mental health inpatient and outpatient treatment. State statues for requiring parental consent favored mental health over drug abuse treatment and inpatient over outpatient modalities. Parental consent was sufficient in 53%-61% of the states for inpatient treatment, but only for 39% - 46% of the states for outpatient treatment.

View Article and Find Full Text PDF

Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression.

J Acquir Immune Defic Syndr

May 2015

*Department of Public Health, AIDS Activities Coordinating Office, Philadelphia, PA; †Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania Philadelphia Veterans Affairs Center for Health Equity Research and Promotion, Philadelphia, PA; ‡Department of City and Regional Planning, School of Design, University of Pennsylvania, Philadelphia, PA; Departments of §Psychiatry; ‖Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and ¶University of Pennsylvania, Treatment Research Institute, Philadelphia, PA.

Background: Previous analyses identified specific geographic areas in Philadelphia (hotspots) associated with negative outcomes along the HIV care continuum. We examined individual and community factors associated with residing in these hotspots.

Methods: Retrospective cohort of 1404 persons newly diagnosed with HIV in 2008-2009 followed for 24 months after linkage to care.

View Article and Find Full Text PDF

The importance of parents as "interventionists" is supported by reviews of the treatment literature (e.g., Smit, Verdurmen, Monshouwer, & Smit, 2008; Winters, Botzet, Fahnhorst, & Koskey, 2009) as well as the emerging science that home-based initiatives by parents can contribute to desired health changes in adolescents (Fearnow, Chassin, Presson, & Sherman, 1998; Jackson & Dickinson, 2006).

View Article and Find Full Text PDF

The purpose of this study was to compare the naturalistic outcomes of parolees and probationers with alcohol and/or opioid problems who were treated with extended-release naltrexone (XR-NTX) to those treated with other medication-assisted therapies or psychosocial treatment only. Methods consisted of using intake and discharge data collected as part of SAMHSA's Treatment Episode Data Set (TEDS) assessments, controlling for group differences using propensity scores that were based on a range of intake variables. Results showed that patients receiving XR-NTX had longer durations of care (compared to oral naltrexone and psychosocial treatment only) and were more likely to become abstinent (compared to oral naltrexone, buprenorphine/naloxone, and psychosocial treatment only).

View Article and Find Full Text PDF

Developing an index to measure the voluntariness of consent to research.

J Empir Res Hum Res Ethics

October 2014

Treatment Research Institute, Philadelphia, PA, USA Saint Joseph's University, Philadelphia, PA, USA.

The goals of the current study were to expand the content domain and further validate the Coercion Assessment Scale (CAS), a measure of perceived coercion for criminally involved substance abusers being recruited into research. Unlike the few existing measures of this construct, the CAS identifies specific external sources of pressure that may influence one's decision to participate. In Phase 1, we conducted focus groups with criminal justice clients and stakeholders to expand the instrument by identifying additional sources of pressure.

View Article and Find Full Text PDF

Background And Objectives: Little is known about the use of extended-release naltrexone (XR-NTX) during residential rehabilitation, and its effects on early outcomes and rates of follow-up treatment. This study examined patient characteristics and rates of treatment completion and engagement in post-residential care of opioid dependent patients who received XR-NTX during residential rehabilitation, compared with patients who did not receive this medication.

Methods: Electronic records for opioid dependent patients from three Pennsylvania residential detoxification and treatment facilities (N = 7,687) were retrospectively analyzed.

View Article and Find Full Text PDF

The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?

Int J Drug Policy

July 2015

Treatment Research Institute, 600 Public Ledger Building, 150 South Independence Mall West, Philadelphia, PA 19106, United States; University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104, United States.

Background: "Bath salts", a derivative of cathinone, a naturally occurring beta-ketone amphetamine analogue found in the leaves of the khat (Catha edulis) plant, is a potent class of designer drugs associated with significant medical and psychiatric consequences. They are commonly used among 20-29 year olds, a group with easy access to the Internet and an inclination to purchase online. Therefore, the Internet has the potential to play a significant role in the distribution and associated consequences of these "legal highs".

View Article and Find Full Text PDF

Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

J Acquir Immune Defic Syndr

April 2015

*Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Treatment Research Institute, Philadelphia, PA; †Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‡Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; §Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD and Department of Pathology, University of Minnesota, Minneapolis, MN; ‖State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China; ¶Department of Family Medicine, Faculty of Medicine, Chiang Mai University; #Guangxi Centers for Disease Control and Prevention, Guangxi Center for HIV/AIDS Prevention and Control, Nanning, China; **Xinjiang Autonomous Region Center for Disease Control and Prevention, Xinjiang, China; ††Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; ‡‡Department of Psychiatry, Yale School of Medicine, New Haven, CT; §§Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD; ‖‖Division of AIDS, Pharmaceutical Affairs Branch, National Institute of Allergy and Infectious Diseases; ¶¶Division of Intramural Research, National Institute of Allergy and Infectious Diseases; ##Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD; ***FHI 360; †††Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division; and ‡‡‡Division of AIDS, Prevention Sciences Branch, National Institute of Allergy and Infectious Diseases.

Background: Injection opioid use plays a significant role in the transmission of HIV infection in many communities and several regions of the world. Access to evidence-based treatments for opioid use disorders is extremely limited.

Methods: HIV Prevention Trials Network 058 (HPTN 058) was a randomized controlled trial designed to compare the impact of 2 medication-assisted treatment (MAT) strategies on HIV incidence or death among opioid-dependent people who inject drugs (PWID).

View Article and Find Full Text PDF

Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.

J Subst Abuse Treat

March 2015

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania and Treatment Research Institute, 600 Public Ledger Bldg; 150 South Independence Mall (W) Philadelphia, PA 19106, USA. Electronic address:

Aims: The aim of this study is to assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine-naloxone (Suboxone®) or methadone.

Methods: Randomized controlled trial with daily observed Suboxone® or methadone and weekly counseling, urine tests and timeline followback (TLFB) in weeks 0-12 and 20, and the Addiction Severity Index (ASI) at weeks 0, 4, 8, 12, 20.

Results: Of the 80 patients (40/group, 4 women), 68 (85%) completed the 12-weeks of study treatment and 66 (82.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research has significantly advanced our understanding of drug abuse treatment for adolescents, exploring various models from brief interventions to intensive therapies.
  • The paper aims to outline key concepts related to adolescent drug issues, including contributing factors to substance use disorders.
  • It also reviews treatment outcomes and highlights areas needing further investigation to improve adolescent drug treatment approaches.
View Article and Find Full Text PDF

Substance use and sexual risk behaviors are common among adolescents. Although attention has focused primarily on alcohol use, less is known about the relationship between marijuana use and sexual risk behavior among high-risk youth. Since truant youth often experience problems in school, troubled family situations, and other psychosocial problems, they represent an important group of high-risk youth to study.

View Article and Find Full Text PDF

Impact of Brief Intervention Services on Drug Using Truant Youth Arrest Charges over Time.

J Child Adolesc Subst Abuse

January 2014

Department of Criminal Justice Temple University 558-9 Gladfelter Hall 1115 West Berks Street Philadelphia, PA 19122 (Also affiliated with Treatment Research Institute, Philadelphia, PA).

School truancy is a serious concern in the U.S., with far-reaching negative consequences.

View Article and Find Full Text PDF

Objectives: Test whether an adaptive program improves outcomes in drug court by adjusting the schedule of court hearings and clinical case-management sessions pursuant to performance criteria.

Methods: Consenting participants in a misdemeanor drug court were randomly assigned to the adaptive program (n = 62) or to a baseline-matching condition (n = 63) in which they attended court hearings based on the results of a criminal risk assessment. Outcome measures were re-arrest rates at 18 months post-entry to the drug court and urine drug test results and structured interview results at 6 and 12 months post-entry.

View Article and Find Full Text PDF

Peer victimization is linked to adjustment problems in youth, including aggressive behavior, yet not all victimized youth are aggressive. The present study investigated whether youth's anger regulation coping might attenuate the positive association between peer victimization and subsequent aggressive behavior. Longitudinal data from 485 7-grade students (55% female, mean age = 12.

View Article and Find Full Text PDF

Background: Patients which have diagnosed with a cancer, have a life time risk for developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. Cancer victims could survive longer due to settling treatment modalities, and then would likely develop a new metachronous malignancy.This article aims to report our observed trend of increasing, in prevalence of both synchronous and metachronous second primary malignancy, among the cancer victims, and to review the relevant literature.

View Article and Find Full Text PDF

Background: This prospective study was conducted to evaluate and compare the efficacies of nasopharyngoscopy and CT scan in the diagnosis of local failure of external beam radiotherapy (EBRT) for nasopharyngeal carcinoma.

Methods: Total 52 patients of histopathologically proven nasopharyngeal carcinoma treated with external beam radiotherapy (EBRT), were included in this study. For every patient computed tomography (CT), nasopharyngoscopy and nasopharyngeal biopsies were performed 3 months after completion of EBRT.

View Article and Find Full Text PDF

Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".

J Acquir Immune Defic Syndr

December 2014

*Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA †Treatment Research Institute, Philadelphia, PA ‡Yale University School of Medicine, New Haven, CT §Oregon Health and Science University, Portland, OR ‖University of California, Los Angeles, Los Angeles, CA ¶University of California, San Francisco, San Francisco, CA #Veterans Affairs Puget Sound Health Care System, Seattle, WA.

View Article and Find Full Text PDF

Truant youths represent a challenging, yet very promising group of at-risk youth to study. In addition to problems in school, they frequently experience troubled family situations, emotional/ psychological problems, involvement in substance use, and delinquency. Given the problems often experienced by truant youth, it is likely they are engaging in alcohol use and sexual risk behavior at a higher rate, than the general youth population.

View Article and Find Full Text PDF